Editorial
Which patients with suspected myocardial ischemia and left bundle-branch block should receive thrombolytic agents?

https://doi.org/10.1067/mem.2001.114761Get rights and content

Abstract

[Gallagher EJ. Which patients with suspected myocardial ischemia and left bundle-branch block should receive thrombolytic agents? Ann Emerg Med. May 2001;37:439-444.]

References (24)

  • AIMS APSAC Intervention Mortality Study Trial Study Group

    Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial

    Lancet

    (1988)
  • Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico GISSI

    Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

    Lancet

    (1986)
  • Cited by (0)

    Reprints not available from the author.

    View full text